During GLP-1RA therapy, sustained hypophagia may further reduce effective micronutrient intake without immediately producing overt deficiency
Glucose-dependent insulinotropic polypeptide, or GIP, works alongside GLP-1 to improve insulin sensitivity and lipid metabolism

Comparison to brand-name products without insurance: - Wegovy list price: ~$1,350/month - Ozempic list price (off-label for weight): ~$1,000/month - Zepbound list price: ~$1,060/month - LillyDirect self-pay Zepbound: ~$350-$550/month depending on dose - Insured commercial with savings card: $25-$550/month depending on plan and product Comparison to competitor telehealth providers: - Vitastir: roughly $200-$400/month for tirzepatide (see Vitastir tirzepatide) - Henry Meds: roughly $300/month flat for compounded tirzepatide - Ivim Health: roughly $270-$370/month depending on dose and term - Mochi Health: roughly $260-$375/month including coaching - Citizen Meds: roughly $200-$375/month (see Citizen Meds tirzepatide) Hidden cost items to ask about: - Dose escalation fees: some providers quietly charge a consultation fee each time you move up a dose tier - Supplies: syringes and alcohol swabs are usually included, but confirm this in writing - Shipping: usually free on an active subscription, sometimes $15-$30 for one-off or expedited orders - Summer cold-chain surcharges: occasionally appear during hot-weather months - Reactivation fees: some providers charge to restart after a pause Value calculation: If your insurance covers brand Wegovy, Ozempic, or Zepbound at a low copay, that is almost always the better choice because you get FDA-approved product with published stability data and a standardized manufacturing process

Smith and Dr
Its small size may support skin penetration, although this also depends heavily on the overall formulation and delivery system
Dosing starts at 2.5mg weekly and can increase to 15mg